Clovis Oncology Inc (CLVS)

Add to Watchlists

Create an Alert

Quickflows

6.62 -0.08 -1.19% NASDAQ Jul 10, 20:00 Delayed 2m USD

Clovis Oncology News

Wire

Headline

Time (ET)
Yahoo

Hedge Funds Never Been Less Bullish On Clovis Oncology Inc (CLVS)

06/30 14:46
Yahoo

Is Clovis Oncology (CLVS) Stock a Solid Choice Right Now?

06/23 08:37
MT Newswires

Alkermes, Clovis Oncology Pre-Clinical Study Supports Potential of Colon Cancer Combination Therapy

06/22 11:08
PR Newswire

New Preclinical Data on ALKS 4230 in Combination With Lucitanib to be Presented at 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II

06/22 09:01
Business Wire

Clovis Oncology to Highlight Rubraca® (rucaparib) and Lucitanib Non-Clinical Data at the AACR Virtual Annual Meeting II 2020

06/17 08:00
Yahoo

Clovis Completes Enrollment in Late-Stage Ovarian Cancer Study

06/11 10:49
Yahoo

The Daily Biotech Pulse: Sorrento Submits EUA Application For Rapid Coronavirus Test, Decision Day For Viela, Lantern Pharma IPO

06/11 08:12
MT Newswires

Clovis Oncology Completes Target Enrollment in Late-Stage Trial for Advanced Ovarian Cancer - Stock Up 1% After-Hours

06/10 17:03
SA Breaking News

Clovis completes enrollment in study of Rubraca combo in ovarian cancer

06/10 16:21
Business Wire

Clovis Oncology Announces Completion of Target Enrollment in the ATHENA Trial, a Phase 3 Maintenance Treatment Study in Front-line, Newly-Diagnosed Advanced Ovarian Cancer

06/10 16:05
Yahoo

Why Is Clovis (CLVS) Down 17.2% Since Last Earnings Report?

06/04 11:31
MT Newswires

Clovis Oncology' Rubraca Added to Guidelines as Treatment for Metastatic Castration-Resistant Prostate Cancer

05/28 11:51
SA Breaking News

Cancer treatment guidelines add new recommendations for Clovis' Rubraca

05/28 08:41
Business Wire

Clovis Oncology Announces New Recommendations for Rubraca® (rucaparib) Tablets in Updated National Comprehensive Cancer Network (NCCN) Guidelines® for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)

05/28 08:00
Yahoo

Edited Transcript of CLVS earnings conference call or presentation 5-May-20 8:30pm GMT

05/28 05:06
MT Newswires

Analyst Actions: HC Wainwright Cuts Clovis Oncology's Price Target to $29 From $33, Reiterates Buy Rating

05/22 11:32
Business Wire

Clovis Oncology Announces Presentations at 2020 ASCO Virtual Scientific Program

05/21 16:10
Yahoo

Clovis Oncology Needs a Savior

05/21 14:24
MT Newswires

Analyst Actions: SVB Leerink Cuts Price Target on Clovis Oncology to $4 From $5, Keeps Underperform Rating

05/20 09:28
Yahoo

8 Biotechs Tapping Secondary Markets for $3 Billion

05/19 18:53

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial

{{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.